MALAYSIA - The recent Biotechnology International Advisory Panel (Bio-IAP) meeting in San Francisco affirmed bioeconomy's key role in Malaysia's aspiration of becoming a high-income developed nation by 2020.
The Malaysian Biotechnology Corporation (BiotechCorp), the agency tasked with driving biotechnology forward in Malaysia, has been working hard to turn it into a game-changing engine for the country's economy.
Given the right focus and strategy, the Bioeconomy Transformation Programme (BTP) will catapult the bioeconomy contribution to Malaysia's Gross Domestic Product from 2 per cent - 3 per cent currently to 8 per cent -10 per cent by 2020.
Sunday Star did an interview with BiotechCorp Chief Executive Officer Datuk Dr Mohd Nazlee Kamal, who talked about their efforts to accelerate its implementation.
What is the Biotechnology International Advisory Panel (Bio-IAP) meeting?
The Bio-IAP was formed out of the National Biotechnology Policy (NBP) launched in May 2005. Comprising biotechnology experts, academics and experienced industry players, the advisory panel's role is to advise Malaysia and help shape the direction and development of its biotechnology sector. The Bio-IAP meeting is held to discuss the development of Malaysia's biotechnology industry from research & development (R&D) initiatives, human capital development, commercialisation, business development to its funding ecosystem.
This year, we decided to hold the meeting with the Third Global Science and Innovation Advisory Council (GSIAC) meeting in San Francisco to converge government officials and related agencies as well as the very busy Prime Minister Datuk Seri Najib Tun Razak with the right experts and industry players.